Use of HDAC inhibitors for the treatment of melanoma

Details for Australian Patent Application No. 2008251499 (hide)

Owner Novartis AG

Inventors Atadja, Peter Wisdom

Agent Davies Collison Cave

Pub. Number AU-A-2008251499

PCT Pub. Number WO2008/141114

Priority 60/938,272 16.05.07 US; 60/917,345 11.05.07 US

Filing date 9 May 2008

Wipo publication date 20 November 2008

International Classifications

A61K 31/4045 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/141114 Priority application(s): WO2008/141114

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008251504-Modulators of CFTR

2008251498-Systems, methods and components for water treatment and remediation